Judo Bio logo

Judo Bio

Creating oligonucleotide medicines delivered to the kidney, silencing target genes to treat systemic and renal diseases.

32 employees · est. 2021 · Cambridge, United States

VS
Omega Therapeutics logo

Omega Therapeutics

Pioneering the first systematic approach to using mRNA as a new class of programmable epigenomic medicines.

72 employees · est. 2017 · Cambridge, United States

Omega Therapeutics is the older company (2021 vs 2017); Omega Therapeutics is the larger of the two.

Side-by-Side Comparison

Judo Bio Omega Therapeutics
Founded
2021 2017 older
Headquarters
Cambridge, United States Cambridge, United States
Employees
32 72 larger
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology, Health Care
Funding Stage
Series A Post Ipo Equity
Total Funding
$100.00M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Not tracked yet
Website
judo.bio omegatherapeutics.com
Judo Bio logo

About Judo Bio

Judo Bio is a biotechnology startup founded in 2021, headquartered in the United States. The company's slogan "Creating oligonucleotide medicines delivered to the kidney, silencing target genes to treat systemic and renal diseases," encapsulates its mission. Judo Bio's pioneering approach involves t...

Omega Therapeutics logo

About Omega Therapeutics

Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines. Our OMEGA platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cel...

We will tell you when either one moves

BounceWatch watches Judo Bio and Omega Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Judo Bio and Omega Therapeutics — by email.

Frequently Asked Questions

Judo Bio — Creating oligonucleotide medicines delivered to the kidney, silencing target genes to treat systemic and renal diseases.. Omega Therapeutics — Pioneering the first systematic approach to using mRNA as a new class of programmable epigenomic medicines. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Judo Bio has raised $100.00M while Omega Therapeutics has raised undisclosed funding.
Judo Bio and Omega Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Judo Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Judo Bio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes